Join Cure MAPT FTD’s Scientific Advisory Board Member Dr. Adam Boxer from the University of California, San Francisco for a Town Hall exploring the rapidly evolving landscape of tau-targeted therapy.
Ensuring access to tau-targeting therapies for MAPT frontotemporal dementia: patient community priorities for regulators and industry. By Linde Jacobs
Cure MAPT FTD member Linde Jacobs spoke at the UCSF Memory and Aging Center Lecture Series in a discussion on genetic FTD.
.jpg)
We offer educational resources, explain options for genetic testing, support group options, and information on FTD resources around the world.
We want YOU to study MAPT FTD! We seek to foster collaboration, share breakthroughs, and accelerate discoveries that will lead to treatments, and ultimately a cure, for MAPT FTD.
.png)
Are you interested in genetic testing? MAPT trials? Support and resources for FTD? Contact us and we'll get back to you quickly.
hello@curemaptftd.org
.png)